Loading...
Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history
Coscolla, M. Gagneux, S. Menardo, F. Loiseau, C. Ruiz-Rodriguez, P. Borrell, S. Otchere, I.D. Asante-Poku, A. Asare, P. Sánchez-Busó, L.
Coscolla, M.
Gagneux, S.
Menardo, F.
Loiseau, C.
Ruiz-Rodriguez, P.
Borrell, S.
Otchere, I.D.
Asante-Poku, A.
Asare, P.
Sánchez-Busó, L.
Publication Date
2021-02
End of Embargo
Supervisor
Rights
© 2021 The Authors. This is an Open Access article published by the Microbiology Society, licensed under a Creative Commons Attribution 4.0 International License.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2020-10-29
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Human tuberculosis (TB) is caused by members of the Mycobacterium tuberculosis complex (MTBC). The MTBC comprises several human-adapted lineages known as M. tuberculosis sensu stricto, as well as two lineages (L5 and L6) traditionally referred to as Mycobacterium africanum. Strains of L5 and L6 are largely limited to West Africa for reasons unknown, and little is known of their genomic diversity, phylogeography and evolution. Here, we analysed the genomes of 350 L5 and 320 L6 strains, isolated from patients from 21 African countries, plus 5 related genomes that had not been classified into any of the known MTBC lineages. Our population genomic and phylogeographical analyses showed that the unclassified genomes belonged to a new group that we propose to name MTBC lineage 9 (L9). While the most likely ancestral distribution of L9 was predicted to be East Africa, the most likely ancestral distribution for both L5 and L6 was the Eastern part of West Africa. Moreover, we found important differences between L5 and L6 strains with respect to their phylogeographical substructure and genetic diversity. Finally, we could not confirm the previous association of drug-resistance markers with lineage and sublineages. Instead, our results indicate that the association of drug resistance with lineage is most likely driven by sample bias or geography. In conclusion, our study sheds new light onto the genomic diversity and evolutionary history of M. africanum, and highlights the need to consider the particularities of each MTBC lineage for understanding the ecology and epidemiology of TB in Africa and globally.
Version
Published version
Citation
Coscolla M, Gagneux S, Menardo F... Mehan CJ... (et al). (2021) Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history. Microbial Genomics. 7 (2).
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article